Aspirin in Primary Prevention: Prudent Guideline-Based Approach Prof. (Dr.) J.P.S. Sawhney13 Jun 2025 11:44 AM ISTAspirin in Primary Prevention: Need for Delineating High CV-Risk, Low-Bleeding-Risk Profiles: Aspirin in primary prevention requires a nuanced,...
Micro Labs Launches Sitanorm-E, Sitagliptin-Empagliflozin FDC for Uncontrolled Type 2 Diabetes in India Deeksha Bhandari6 Jun 2025 12:11 PM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin. The combination is formulated to...
ADA/CRP ratio may help differentiate Tuberculous from Malignant pleural effusion Aditi10 Oct 2023 8:00 PM ISTTuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) display similar cytological and biochemical pictures, including adenosine...
American Diabetes Association releases guideline update on NAFLD in People with diabetes MD Brand Connect13 July 2023 11:15 AM ISTPioglitazone/GLP1 RA are the preferred agents for the treatment of hyperglycemia in people with T2DM diabetes with NAFLD or those at high risk of...
Important Updates to the Standards of Medical Care in Diabetes-2022 Incorporate New Evidence Dr. Kamal Kant Kohli13 Jun 2022 9:15 AM ISTToday, the American Diabetes Association (ADA) published important updates to the Standards of Medical Care in Diabetes-2022 (Standards of Care), in...
Custom program helps people living with diabetes control blood sugar Dr. Nandita Mohan10 Jun 2022 9:00 AM ISTStudy results from three clinical trials has showed that a "WeightWatchers" program which was tailored for people living with diabetes helped...
AI Offers Significant Rate of Remission for Type 2 Diabetes Compared to Standard Care Dr. Kamal Kant Kohli9 Jun 2022 7:30 PM ISTA new study powered by artificial intelligence (AI), Whole Body Digital Twin, reveals the highest reported rate of remission of type 2 diabetes to...
Individuals with Diabetes Up to Four Times More Likely to Develop Long COVID-19 Dr. Kamal Kant Kohli7 Jun 2022 9:30 AM ISTA new study reveals that diabetes is a potential risk factor for post-acute sequelae of COVID-19 (PASC), also known as long COVID-19, a range of...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 9:15 AM ISTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Indoor masking in dental practices: American Dental Association guidelines Dr. Shravani Dali19 May 2022 6:00 AM ISTThe Association March 2 released a new resource for members to help dental practices make informed decisions and facilitate conversations about the...
Pharmacological Treatment of Diabetes: ADA 2022 explores beyond metformin as initial therapy Dr. Prem Aggarwal24 Dec 2021 4:00 PM ISTNew Delhi: Metformin has been the cornerstone of Diabetes management for a long time. However, with the growing research in the field of diabetes and...
ADA releases standard of medical care in 2022, here are the important details Dr. Nandita Mohan23 Dec 2021 5:51 PM ISTBased upon the latest scientific diabetes research and clinical trials, the Standards of Care is the gold-standard for professionals in the medical...
